Excelsior Biopharma Inc. (TPEX:6496)
Taiwan · Delayed Price · Currency is TWD 25.00
+0.10 (0.40%)
Aug 19, 2026, 1:30 PM CST
Excelsior Biopharma Market Cap
Excelsior Biopharma has a market cap or net worth of 1.16 billion as of August 19, 2026. Its market cap has decreased by -12.17% in one year.
Market Cap
1.16B
Enterprise Value
1.54B
Revenue
936.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.00
ChartMarket Cap Chart
Since December 23, 2014, Excelsior Biopharma's market cap has decreased from 2.86B to 1.16B, a decrease of -59.51%. That is a compound annual growth rate of -7.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.16B | -15.18% |
| Dec 31, 2025 | 1.37B | -2.78% |
| Dec 31, 2024 | 1.41B | 3.69% |
| Dec 29, 2023 | 1.36B | 4.50% |
| Dec 30, 2022 | 1.30B | -4.79% |
| Dec 30, 2021 | 1.36B | -1.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PhytoHealth | 2.23B |
| TSH Biopharm Corporation | 1.94B |
| GeneFerm Biotechnology | 1.27B |
| InnoPharmax | 1.23B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 1.03B |
| Original BioMedicals | 942.23M |
| Anxo Pharmaceutical | 919.08M |